Dr Reddy’s launches insomnia drug in US

Hyderabad: Dr Reddy’s Laboratories launched Eszopiclone Tablets (C-IV), useful in treatment of insomnia, in the US market on Tuesday. It comes in dosages of one, two and three mg respectively.

The drug is a therapeutic equivalent generic version of LUNESTA (eszopiclone) tablets C-IV. Dr Reddy’s has obtained approval from the US drug regulator, the Food and Drug Administration. Lunesta is a registered trademark of Sunovion Pharmaceuticals Inc.

The Lunesta (eszopiclone) tablets C-IV brand and generic combined had US sales of approximately $887 million for the twelve months ending January 2014, according to IMS Health.

Dr Reddy’s Eszopiclone tablets (C-IV) one mg is available in bottle counts of 30, while two and three mg are available in bottle counts of 100, according to a company press release.

Disclaimer: This information has been collected through secondary research and IBEF is not responsible for any errors in the same.